Company Filing History:
Years Active: 2013-2015
Title: Masashi Ishigami: Innovator in Pharmaceutical Crystallization
Introduction
Masashi Ishigami is a notable inventor based in Yoshinogari, Japan. He has made significant contributions to the field of pharmaceutical crystallization, particularly through his work on tetomilast polymorphs. With a total of 3 patents to his name, Ishigami's innovations are paving the way for advancements in drug formulation.
Latest Patents
Ishigami's latest patents focus on the development of tetomilast crystals that can be produced industrially in large volumes. His inventions include: (1) a tetomilast hydrate crystal with a specific powder X-ray diffraction spectrum; (2) an anhydrous tetomilast type A crystal with a similar diffraction spectrum; (3) an anhydrous tetomilast type C crystal; (4) a tetomilast acetonitrile solvate crystal; and (5) a mixture of anhydrous tetomilast type A and type B crystals. These crystals exhibit stability against heat and moisture, and they demonstrate excellent disintegration and dissolution properties, making them ideal for pharmaceutical compositions.
Career Highlights
Masashi Ishigami is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in enhancing the quality and efficacy of pharmaceutical products.
Collaborations
Ishigami has collaborated with notable colleagues such as Satoshi Aoki and Kenji Nakaya, contributing to a dynamic research environment that fosters innovation.
Conclusion
Masashi Ishigami's contributions to pharmaceutical crystallization through his patents on tetomilast polymorphs highlight his role as a key innovator in the industry. His work not only advances pharmaceutical science but also improves the quality of medications available to patients.